share_log

Arteris Insiders Benefit From Selling Stock At US$6.48

Arteris Insiders Benefit From Selling Stock At US$6.48

Arteris內部人士受益於以6.48美元的價格出售股票
Simply Wall St ·  05/04 10:10

Even though Arteris, Inc. (NASDAQ:AIP) stock gained 23% last week, insiders who sold US$235k worth of stock over the past year are probably better off. Holding on to stock would have meant their investment would be worth less now than it was at the time of sale. Thus selling at an average price of US$6.48, which is higher than the current price, may have been the best decision.

儘管上週Arteris公司(納斯達克股票代碼:AIP)的股票上漲了23%,但在過去一年中出售了價值23.5萬美元股票的內部人士的境況可能更好。持有股票意味着他們現在的投資價值將低於出售時的價值。因此,以6.48美元的平均價格(高於當前價格)出售可能是最好的決定。

Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares.

儘管我們認爲股東不應該簡單地關注內幕交易,但邏輯要求你應該注意內部人士是在買入還是賣出股票。

The Last 12 Months Of Insider Transactions At Arteris

Arteris最近 12 個月的內幕交易

In the last twelve months, the biggest single sale by an insider was when the Chairman, Karel Janac, sold US$71k worth of shares at a price of US$7.03 per share. That means that even when the share price was below the current price of US$8.21, an insider wanted to cash in some shares. When an insider sells below the current price, it suggests that they considered that lower price to be fair. That makes us wonder what they think of the (higher) recent valuation. While insider selling is not a positive sign, we can't be sure if it does mean insiders think the shares are fully valued, so it's only a weak sign. This single sale was just 0.1% of Karel Janac's stake.

在過去的十二個月中,內部人士最大的一次出售是董事長卡雷爾·賈納克以每股7.03美元的價格出售了價值7.1萬美元的股票。這意味着,即使股價低於當前的8.21美元,內部人士也想套現一些股票。當內部人士以低於當前價格的價格出售時,這表明他們認爲較低的價格是公平的。這讓我們想知道他們如何看待最近(更高的)估值。儘管內幕拋售不是一個積極的信號,但我們無法確定這是否意味着內部人士認爲股票已完全估值,因此這只是一個弱勢信號。此次出售僅佔卡雷爾·賈納克股份的0.1%。

In the last year Arteris insiders didn't buy any company stock. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!

去年,Arteris內部人士沒有購買任何公司股票。你可以在下面看到過去 12 個月內幕交易(公司和個人)的直觀描述。通過點擊下面的圖表,你可以看到每筆內幕交易的確切細節!

insider-trading-volume
NasdaqGM:AIP Insider Trading Volume May 4th 2024
納斯達克通用汽車公司:AIP 內幕交易量 2024 年 5 月 4 日

For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

對於那些喜歡尋找中獎投資的人來說,這份最近有內幕收購的成長型公司的免費名單可能只是門票。

Insiders At Arteris Have Sold Stock Recently

Arteris的內部人士最近出售了股票

The last quarter saw substantial insider selling of Arteris shares. In total, insiders dumped US$163k worth of shares in that time, and we didn't record any purchases whatsoever. Overall this makes us a bit cautious, but it's not the be all and end all.

上個季度,Arteris股票遭到大量內幕拋售。在此期間,內部人士總共拋售了價值16.3萬美元的股票,我們沒有記錄任何購買記錄。總的來說,這使我們有點謹慎,但這並不是萬能的。

Insider Ownership Of Arteris

Arteris的內部所有權

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. We usually like to see fairly high levels of insider ownership. Arteris insiders own about US$73m worth of shares. That equates to 32% of the company. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.

我喜歡看看內部人士在一家公司擁有多少股票,以幫助我了解他們與內部人士的看法。我們通常希望看到相當高的內部所有權水平。Arteris內部人士擁有價值約7300萬美元的股票。這相當於該公司的32%。這種內部所有權水平不錯,但還沒有特別突出。這無疑表明了一定程度的一致性。

So What Do The Arteris Insider Transactions Indicate?

那麼,Arteris內幕交易表明了什麼呢?

Insiders sold stock recently, but they haven't been buying. And even if we look at the last year, we didn't see any purchases. Insider ownership isn't particularly high, so this analysis makes us cautious about the company. We're in no rush to buy! In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Arteris. Case in point: We've spotted 4 warning signs for Arteris you should be aware of.

內部人士最近出售了股票,但他們一直沒有買入。而且,即使我們看看去年,我們也沒有看到任何購買。內部所有權並不是特別高,因此這種分析使我們對公司持謹慎態度。我們並不急於購買!除了了解正在進行的內幕交易外,確定Arteris面臨的風險也是有益的。一個很好的例子:我們發現了4個你應該注意的動脈炎警告信號。

But note: Arteris may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

但請注意:Arteris可能不是最好的買入股票。因此,來看看這份投資回報率高、債務低的有趣公司的免費清單。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,內部人士是指向相關監管機構報告其交易的個人。我們目前只考慮公開市場交易和私下處置的直接利益,不包括衍生品交易或間接權益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論